Unibest
← Back to patent-cliff list

CAS 15862-86-9

DL-Pipecolic acid hydrochloride

Codes: (II)91311-2-a

Application context (from source-drug indications)

PainBupivacaine Hydrochloride/Fentanyl CitrateSubacromial impingement syndromeBupivacainePostoperative painBupivacaineStomatitisBupivacaineHead and neck cancerBupivacaineHypotensionBupivacaineMitral regurgitationBupivacaine

Source drugs (routes using this intermediate)

DrugTierExpiry
Bupivacaine Hydrochloride/Fentanyl CitrateTier C — Watch / trade-
BupivacaineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Bupivacaine Hydrochloride/Fentanyl CitrateOptimised routesteps: 4total yield: /
(+/-)-Piperidine-2-carboxylic acid→DL-Pipecolic acid hydrochloride→Piperidine-2-carbonyl chloride hydrogen chloride→2-Amino-1,3-dimethylbenzene→(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide→1-Bromobutane
BupivacaineOptimised routesteps: 4total yield: /
(+/-)-Piperidine-2-carboxylic acid→DL-Pipecolic acid hydrochloride→Piperidine-2-carbonyl chloride hydrogen chloride→2-Amino-1,3-dimethylbenzene→(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide→1-Bromobutane

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.